Upfront with Algernon Pharmaceuticals CEO Chistopher J Moreau – Episode 4

 

The interview series with Algernon Pharmaceuticals CEO Christopher Moreau and PRmediaNow host Cyndi Edwards continues. In today’s episode, Mr. Moreau discusses recent news regarding the Company’s positive feedback received on its Planned Phase 1/2a DMT Human Stroke Study.

Share via
Copy link
Powered by Social Snap